MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2023-24)
- Udyam number
- UDYAM-UP-50-0019979
Ubnap Pharmaceuticals Private Limited
Ubnap Pharmaceuticals Private Limited - pharma in Lucknow, Uttar Pradesh, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹35.24 Lakh
▲ 79% YoY
Net profit · FY 2025
₹5,767
Net margin 0.2%
EBITDA · FY 2025
₹20,085
EBITDA margin 0.6%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Open charges
₹5 Lakh
Secured borrowings
Company age
6 yrs
Est. 2020
Directors on board
2
As per MCA filings
About Ubnap Pharmaceuticals Private Limited
Data last updated:
Ubnap Pharmaceuticals Private Limited is a private limited company based in Lucknow, Uttar Pradesh, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 23 May 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Uttar Pradesh, under CIN U24302UP2020PTC128761. Its GSTIN is 09AACCU5938L1ZQ (Uttar Pradesh).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Navanit Kumar Srivastava (Managing Director) and Praveen.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at P.No – K – 2D Kh.No – 641 Govind Vihar Kanchanpur Matiyari Chinhat, Lucknow, Uttar Pradesh, India – 226028.
As per the financials filed for FY 2025, the company reported a revenue of ₹35.24 Lakh, a growth of 79% compared to the previous year. For the same year it recorded a net profit of ₹5,767 (net margin 0.2%) and EBITDA of ₹20,085 (EBITDA margin 0.6%). Revenue has grown at a compounded annual rate (CAGR) of 32% over three years.
As per MCA filings, the company has open charges of ₹5 Lakh on record.
Ubnap Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-UP-50-0019979).
Company details
CIN U24302UP2020PTC128761
Registration Number 128761
Incorporation Date 23 May 2020
ROC Uttar Pradesh
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-UP-50-0019979
Recognitions & Rankings of Ubnap Pharmaceuticals
Contact details
Ubnap Pharmaceuticals Private Limited's registered office is in Lucknow, Uttar Pradesh. Its e-mail address is in the company report.
- Email
- Registered AddressP.No – K – 2D Kh.No – 641 Govind Vihar Kanchanpur Matiyari Chinhat, Lucknow, Uttar Pradesh, India – 226028
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Ubnap Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Ubnap Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Ubnap Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Ubnap Pharmaceuticals Private Limited, buy the company report.
Financials of Ubnap Pharmaceuticals Private Limited
FY 2025 filings availableUbnap Pharmaceuticals Private Limited reported revenue of ₹35.24 Lakh (up 79% YoY) for FY 2025.
Revenue · FY 2025
₹35.24 Lakh ▲ 79%
Net profit · FY 2025
₹5,767 margin 0.2%
EBITDA · FY 2025
₹20,085 margin 0.6%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 79%
3 years · compounded
▲ 32%
EBITDA CAGR growth
1 year
▼ 83%
3 years · compounded
▼ 45%
Revenue has grown at a compounded annual rate (CAGR) of 32% over three years, including 79% growth in the latest year. EBITDA fell 83% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹20,085 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹5,767 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0.6% | ||||
| Net Profit Margin | 0.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Ubnap Pharmaceuticals Private Limited, buy the company report.
Board of directors of Ubnap Pharmaceuticals Private Limited
Ubnap Pharmaceuticals has 2 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Praveen | Director | 23 May 2020 | 6 Years 5 Months | Current |
| Navanit Kumar Srivastava Also directs: Absolute Medicare Solutions Private Limited | Managing Director | 23 May 2020 | 6 Years 5 Months | Current |
Peer comparison
Ubnap Pharmaceuticals Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Agena Pharmaceuticals Private Limited | ₹35.6 Lakh (FY 2023) | 102.0% | Kushinagar, Uttar Pradesh, India | |||
| Siyora Pharmaceuticals Private Limited | ₹35.31 Lakh (FY 2023) | 16.0% | Mumbai, Maharashtra, India | |||
| Ubnap Pharmaceuticals Private Limitedthis company | ₹35.24 Lakh (FY 2025) | ₹5,767 | 0.2% | 79.0% | Lucknow, Uttar Pradesh, India | |
| Npvet Pharmaceuticals Private Limited | ₹35.02 Lakh (FY 2025) | 29.0% | Jhansi, Uttar Pradesh, India | |||
| Peregrine Falcon Pharmaceuticals Private Limited | ₹34.9 Lakh (FY 2025) | -10.0% | Kolkata, West Bengal, India |
To see the full peer comparison of Ubnap Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
Open charges
₹5 Lakh
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 21 Jun 2024 | 100947276 | Idbi Bank Limited | ₹5 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Ubnap Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Ubnap Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Ubnap Pharmaceuticals Private Limited has 1 active EPFO establishment as of Mar 28, 2024.
Active EPFO establishments
1
GST
Ubnap Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AACCU5938L1ZQ | Uttar Pradesh | Active | 13 May 2022 |
To see the full GST registrations and return filing status of Ubnap Pharmaceuticals Private Limited, buy the company report.
Recent activity
Ubnap Pharmaceuticals Private Limited has 2 board changes on record since 2020: 2 appointments. The latest: Navanit Kumar Srivastava was appointed as Managing Director on 23 May 2020.
AGM
Ubnap Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Ubnap Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Uttar Pradesh I.
Charges
A charge with Idbi Bank Limited amounted to Rs. 5.00 Lakh with Charge ID 100947276 was registered on 21 Jun 2024.
Appointed
Navanit Kumar Srivastava was appointed as Managing Director.
Appointed
Praveen was appointed as Director.
Incorporation
23 May 2020
Ubnap Pharmaceuticals Private Limited was registered on 23 May 2020 with Roc Uttar Pradesh I & aged 6 years 5 months as per MCA records.
Frequently asked questions
Ubnap Pharmaceuticals is an active private limited company based in Lucknow, Uttar Pradesh, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 23 May 2020 (6+ years old) and is registered under CIN U24302UP2020PTC128761.
Ubnap Pharmaceuticals has 2 current directors:
- Navanit Kumar Srivastava - Managing Director
- Praveen - Director
The latest financial statements of Ubnap Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The GSTIN of Ubnap Pharmaceuticals is 09AACCU5938L1ZQ, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Ubnap Pharmaceuticals is U24302UP2020PTC128761. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Ubnap Pharmaceuticals was incorporated on 23 May 2020, making it 6+ years old. It is registered with the Registrar of Companies, Uttar Pradesh.
The peers of Ubnap Pharmaceuticals by revenue are Agena Pharmaceuticals Private Limited, Siyora Pharmaceuticals Private Limited, Npvet Pharmaceuticals Private Limited, Peregrine Falcon Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Navanit Kumar Srivastava was appointed as Managing Director on 23 May 2020. Praveen was appointed as Director on 23 May 2020.
Yes, Ubnap Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-UP-50-0019979).
The registered office of Ubnap Pharmaceuticals is at P.No – K – 2D Kh.No – 641 Govind Vihar Kanchanpur Matiyari Chinhat, Lucknow, Uttar Pradesh, India – 226028.
Ubnap Pharmaceuticals operates in the pharma industry, in the pharmaceutical retailers and distributors segment.